Targeted Pediatric High-Grade Glioma Therapy
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- Nationwide Children's Hospital
- Study ID
- NCT05839379
- Status
- Recruiting
Conditions
- Anaplastic Astrocytoma
- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma, H3 K27M-Mutant
- Glioblastoma
- Glioblastoma Multiforme
- High Grade Glioma
- Metastatic Brain Tumor
- WHO Grade III Glioma
- WHO Grade IV Glioma
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Months - 39 Years
- Healthy Volunteers
- Not accepted
Study Details
The goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult patients who have been newly diagnosed with a high-grade glioma. This molecular profiling will decide if patients are eligible to participate in a subsequent treatment-based clinical trial based on the genetic alterations identified in their tumor.
Key Dates
- Start date
- Aug 2, 2024
- Status verified
- Sep 2025
- Primary completion
- Aug 28, 2029
- Completion
- Aug 28, 2034
Study Design
- Enrollment
- 350 participants (estimated)
Primary Outcome Measure
Molecular profiling [ Time Frame: 4 years ]
Central Contacts
- Kelsey H Troyer, PhD16147223284
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital Colorado | Aurora | Colorado | 80045 | |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | |
| C.S. Mott Children's Hospital | Ann Arbor | Michigan | 48109 | |
| Duke University Health System | Durham | North Carolina | 27708 | |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | |
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | |
| Texas Children's Hospital | Houston | Texas | 77030 | |
| Seattle Children's Hospital | Seattle | Washington | 98105 |
Find similar trials in Aurora, CO
By condition
By specialty
By research site
Related Studies
- Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem GliomaRecruiting · Children's National Research Institute · Washington D.C., District of Columbia
- Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated GliomaPHASE1/PHASE2 · Recruiting · Neonc Technologies, Inc. · Los Angeles, California
- INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)PHASE2 · Recruiting · Patrick Wen, MD · Birmingham, Alabama
- International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and RepositoryRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio